State of Alaska Department of Revenue Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

State of Alaska Department of Revenue reduced its position in DaVita Inc. (NYSE:DVA) by 4.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,144 shares of the company’s stock after selling 215 shares during the period. State of Alaska Department of Revenue’s holdings in DaVita were worth $769,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Exchange Traded Concepts LLC bought a new stake in shares of DaVita in the 3rd quarter worth $135,000. Vontobel Holding Ltd. increased its holdings in DaVita by 17.2% in the 3rd quarter. Vontobel Holding Ltd. now owns 2,243 shares of the company’s stock worth $368,000 after buying an additional 329 shares in the last quarter. Capital Investment Advisors LLC purchased a new position in DaVita in the 3rd quarter worth about $213,000. Blue Trust Inc. lifted its stake in DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after acquiring an additional 119 shares during the period. Finally, Raymond James & Associates boosted its holdings in shares of DaVita by 93.6% during the 3rd quarter. Raymond James & Associates now owns 31,316 shares of the company’s stock valued at $5,134,000 after acquiring an additional 15,138 shares during the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Stock Down 11.4 %

DVA stock opened at $156.95 on Friday. The business’s 50-day moving average is $161.41 and its two-hundred day moving average is $157.37. The company has a market cap of $12.87 billion, a price-to-earnings ratio of 16.93, a P/E/G ratio of 0.84 and a beta of 0.94. DaVita Inc. has a fifty-two week low of $118.56 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 6.53% and a return on equity of 88.18%. As a group, analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Barclays boosted their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.